| 10-27 10:06 | AstraZeneca, Daiichi Sankyo's Enhertu Wins First EU Approval In Early Breast Cancer Setting | www.rttnews.com |
| 10-26 20:36 | GSK and Hansoh's experimental bone cancer drug delayed progression in a late-stage China study | digg.com |
| 10-26 20:26 | 'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer Trial | www.newslocker.com |
| 10-26 20:26 | 'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer Trial | www.newslocker.com |
| 10-26 20:26 | 'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer Trial | www.newslocker.com |
| 10-26 17:00 | Xencor Drug Shows Unprecedented Profile in Colorectal Cancer: Analyst | www.benzinga.com |
| 10-26 14:27 | Novel Drug Doubles PFS in Heavily Pretreated, HR-Positive Breast Cancer | www.newslocker.com |
| 10-26 14:27 | Novel Drug Doubles PFS in Heavily Pretreated, HR-Positive Breast Cancer | www.newslocker.com |
| 10-26 14:27 | Novel Drug Doubles PFS in Heavily Pretreated, HR-Positive Breast Cancer | www.newslocker.com |
| 10-26 13:31 | BioNTech Evaluates Next Steps as Breast Cancer Drug Shows Limited Patient Benefit | www.benzinga.com |
| 10-26 13:23 | Amgen, AstraZeneca Drug Combo Shows Promising Survival Results in Tough-To-Treat Lung Cancer | www.benzinga.com |
| 10-26 11:44 | AstraZeneca's Sone-Ve Cuts Death Risk By 42% In Advanced Gastric Cancer Trial; Stock Up | www.rttnews.com |
| 10-26 11:30 | AstraZeneca's Tagrisso Combo Achieves Significant Survival Benefit In Lung Cancer Trial; Stock Up | www.rttnews.com |
| 10-26 10:09 | Amgen And AstraZeneca's IMDELLTRA Plus IMFINZI Cuts Death Risk By 58% In Small Cell Lung Cancer | www.rttnews.com |
| 10-26 09:00 | A new cancer drug costs as much as a home down payment each month. Doctors say that's greed, not health care | www.newslocker.com |
| 10-26 09:00 | A new cancer drug costs as much as a home down payment each month. Doctors say that's greed, not health care | www.newslocker.com |
| 10-26 09:00 | A new cancer drug costs as much as a home down payment each month. Doctors say that's greed, not health care | www.newslocker.com |
| 10-26 06:32 | Roche Targets Emerging Oncology Market With New Lung-Cancer Drug | www.newsylist.com |
| 10-26 04:32 | AstraZeneca Readies New Portfolio of Targeted Cancer Therapies | www.newsylist.com |
| 10-26 00:53 | Roche’s experimental lung-cancer drug showed almost six months longer survival than two rival drugs in a late-stage study | digg.com |
| 10-25 18:55 | New Lung Cancer Drug Combination Extends Survival in Aggressive Microcytoma | www.archynewsy.com |
| 10-25 17:50 | Liver cancer cells’ own carbon monoxide powers anticancer drug production in lab tests | digg.com |
| 10-25 16:11 | AstraZeneca's experimental stomach cancer drug doubled survival time in late-stage trial | digg.com |
| 10-25 10:44 | 'Six years on, I'm still stable': Finally a shred of hope for deadly lung cancer patients as NHS drug gives precious extra months of life | www.newslocker.com |
| 10-24 23:32 | Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer | www.newsylist.com |
| 10-24 13:06 | Johnson & Johnson’s prostate cancer drug shrinks tumours in early-stage trial | www.newslocker.com |
| 10-23 23:13 | Chinese Drug Shows Benefit in HER2-Low Breast Cancer | www.newslocker.com |
| 10-23 23:13 | Chinese Drug Shows Benefit in HER2-Low Breast Cancer | www.newslocker.com |
| 10-23 23:13 | Chinese Drug Shows Benefit in HER2-Low Breast Cancer | www.newslocker.com |
| 10-23 15:36 | Why Is Tango Therapeutics Stock Trading Lower After Cancer Drug Data? | www.benzinga.com |
| 10-23 13:01 | Zymeworks Licenses Cancer Drug Candidate ZW209 To Roche In Deal Worth Up To $813 Million | www.rttnews.com |
| 10-23 10:30 | Tango Therapeutics Just Improved On This 'Unprecedented' Cancer Drug | www.investors.com |
| 10-22 13:31 | BioNTech Advances Phase 3 Trial of Pumitamig With Gilead’s Cancer Drug | wealthawesome.com |
| 10-21 06:27 | Dr Reddy's receives DCGI approval for esophageal cancer drug Zytorvi | www.business-standard.com |
| 10-21 06:27 | Dr Reddy's receives DCGI approval for esophageal cancer drug Zytorvi | www.business-standard.com |
| 10-17 20:05 | Cancer Drug Sales to Reach $311 Billion by 2031 | www.archynewsy.com |
| 10-16 00:16 | AstraZeneca strikes $40 million AI drug discovery deal with insitro | www.newslocker.com |
| 10-14 17:03 | Gilead Sciences Partners with Vir Biotechnology for Cancer Drug Development | wealthawesome.com |
| 10-12 22:03 | Bristol Myers cancer drug slows rare tumor progression | www.newslocker.com |
| 10-12 17:32 | AstraZeneca blames trial design for Phase 3 failure of bone disease drug | www.newsylist.com |
| 10-12 13:21 | AstraZeneca Says Rare Disease Drug Shows Improvements in Inherited Bone Disorder Despite Missing Key Trial Goal | www.benzinga.com |
| 10-08 16:51 | Ontario narrows out-of-country drug funding rules after cancer patient court victory | www.newslocker.com |
| 10-08 16:51 | Ontario narrows out-of-country drug funding rules after cancer patient court victory | www.newslocker.com |
| 10-08 16:51 | Ontario narrows out-of-country drug funding rules after cancer patient court victory | www.newslocker.com |
| 10-08 16:51 | Ontario narrows out-of-country drug funding rules after cancer patient court victory | www.newslocker.com |
| 10-08 14:50 | Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGIS | www.rttnews.com |
| 10-08 08:32 | Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance | www.newsylist.com |
| 10-07 09:07 | AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment - CNBC | newpost24.site |
| 10-06 18:13 | Kairos Pharma Targets Drug Resistance Mechanism Against Prostate Cancer | www.benzinga.com |
| 10-06 18:09 | ArriVent BioPharma Lung Cancer Drug Fails Primary Trial Endpoint, Stock Hits 52-Week Low | www.benzinga.com |
| 10-06 16:01 | Cancer trial drug zavondemstat reportedly largely blocks DHODH rather than KDM4 | digg.com |
| 10-06 10:55 | First U.S. Patient Receives Telix's Newly Approved Brain Cancer Imaging Drug | www.rttnews.com |
| 10-05 21:52 | AstraZeneca CEO Says Summit Drug Could Drive Cancer Combos | www.newsy-today.com |
| 10-05 09:07 | Drug-Resistant Klebsiella Outbreak in Cancer Patients Exposes Hidden Hospital Risks | cedarnews.net |
| 10-04 11:35 | British Indian pair, accused of cancer drug fraud, fight extradition to US | www.newslocker.com |
| 10-02 19:41 | Cancer GoFundMe Shut Down; 'Dialed Down' Drug Price Plan; Binge Drinking and Cancer | www.newslocker.com |
| 10-02 19:41 | Cancer GoFundMe Shut Down; 'Dialed Down' Drug Price Plan; Binge Drinking and Cancer | www.newslocker.com |
| 10-02 19:41 | Cancer GoFundMe Shut Down; 'Dialed Down' Drug Price Plan; Binge Drinking and Cancer | www.newslocker.com |
| 10-02 13:29 | <![CDATA[Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Ther | www.pharmexec.com |
| 10-02 13:28 | AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership | www.benzinga.com |
| 10-02 07:40 | Daiichi Sankyo, AstraZeneca, Summit Partner On Datroway- Ivonescimab Cancer Studies | www.rttnews.com |
| 10-02 07:02 | Astrazeneca, Daiichi Sankyo Add Summit to Datroway Combination Push | business20channel.tv |
| 10-01 10:12 | AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial | www.newsylist.com |
| 09-29 15:27 | AstraZeneca und Summit: 2-Milliarden-Deal sorgt für Kursfantasie | www.newslocker.com |
| 09-29 14:30 | AstraZeneca invests $2 billion in Summit Therapeutics | digg.com |
| 09-29 13:40 | AstraZeneca Pays $2 Billion To Get Into High-Profile Cancer Space | www.investors.com |
| 09-29 13:19 | Summit Therapeutics Stock Jumps On $2B AstraZeneca Deal | www.timothysykes.com |
| 09-29 13:12 | AstraZeneca Invests in Summit Therapeutics after Year of Speculation | www.benzinga.com |
| 09-29 12:33 | Summit Therapeutics Stock Jumps On $2B AstraZeneca Deal And Trial Wins | stockstotrade.com |
| 09-29 11:48 | Summit Therapeutics Stock Pops As AstraZeneca Commits $2B | www.timothysykes.com |
| 09-29 11:48 | Summit Therapeutics Soars On $2B AstraZeneca Bet And Trial Wins | stockstotrade.com |
| 09-29 11:21 | India’s Supreme Court questions 10x hospital markup on cancer drug | digg.com |
| 09-29 10:57 | Summit Therapeutics Soars Nearly 20% After AstraZeneca Bets $2 Billion on Cancer Drug Ivonescimab | www.benzinga.com |
| 09-29 08:27 | AstraZeneca files FDA application for lung cancer treatment Orpathys | www.archynewsy.com |
| 09-29 07:33 | Astrazeneca investiert 2 Mrd USD in Summit Therapeutics - Kooperation vertieft | www.newslocker.com |
| 09-29 03:37 | Merck to Pay Up to $2.13 Billion in Cancer Drug Deal with SciBrunch Therapeutics | www.archynewsy.com |
| 09-29 03:29 | AstraZeneca Invests $2 Billion In Summit, Expands Cancer Drug Collaboration; Stock Up | www.rttnews.com |